Regular update of the Norwegian Laboratory Code System released

On September 23, 2024, the Norwegian Directorate of Health released an updated version of the Norwegian Laboratory Code (NLK) system (Norsk laboratoriekodeverk 7280.73). The associated tariffs (Laboratoriekodeverk som gir rett til refusjon) are not yet available. NLK system is used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) for laboratory tests performed in outpatient settings.

Sixty-nine new codes were added, 209 codes were changed, and 16 codes were terminated. New codes belong to biochemistry, microbiology, clinical pharmacology, immunology, and transfusiology areas. Some examples of newly added codes are provided below.

• NPU60907 P-GFAP (Glial fibrillary acidic protein) (plasma);
• NPU62252 Us-Streptococcus anginosus group DNA (unspecified sample);
• NPU62805 P-Cysticercus antigen (plasma);
• NPU62829 Us-Acanthamoeba culture (unspecified sample);
• NPU62872 Us-Cefotetan+Cloxacillin (unspecified sample, sensitivity);
• NPU62873 Us-Doripenem (unspecified sample, sensitivity);
• NOR35334 U-Fentanyl (non-specific) (urine);
• NOR35335 U-Clonazepam (non-specific) (urine);
• NPU60804 P-IgE Api m 1 (bee venom), i208 (plasma);
• NPU62731 P-IgE Pol d 5 (wasp venom), i210 (plasma).

See the full details in Norwegian here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.